Related Experiment Video
Updated: Nov 19, 2025

05:23
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
6.3K
Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality
Bushra Mdkhana1, Narjes Saheb Sharif-Askari1, Rakhee K Ramakrishnan1
1Sharjah Institute of Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Journal of Inflammation Research
|February 3, 2021
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evades innate immune responses by manipulating nucleic acid-sensing pathways. Targeting these pathways may control COVID-19 progression and cytokine storms.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, necessitates understanding viral pathobiology and immune responses.
- Limited effective antiviral therapies and vaccines highlight the need for novel therapeutic strategies.
Purpose of the Study:
- To review evidence on SARS-CoV-2-induced innate nucleic acid-sensing pathways.
- To elucidate viral immune evasion mechanisms impacting these pathways.
- To explore therapeutic targeting of these pathways for COVID-19 treatment.
Main Methods:
- Literature review of current evidence on SARS-CoV-2 and innate immune sensing.
- Analysis of viral mechanisms for immune evasion.
- Discussion of therapeutic strategies targeting nucleic acid-sensing pathways.
Main Results:
- SARS-CoV-2 activates NOD-signaling and NLRP3 pathways, increasing inflammatory cytokines (IL-1β, IL-6).
- SARS-CoV-2 inhibits cGAS-STING and interferon pathways, reducing antiviral responses.
- This immune evasion promotes viral replication and infection.
Conclusions:
- Modulating nucleic acid-sensing pathways offers a therapeutic approach for COVID-19.
- Blocking inflammation and boosting interferon production could control viral spread and prevent cytokine storms.
- Targeting these pathways may lead to effective COVID-19 treatments.

